Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
602
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
+2.02M
-
Total reported value, excl. options
-
$10.3B
-
Value change
-
+$408M
-
Put/Call ratio
-
0.79
-
Number of buys
-
313
-
Number of sells
-
-276
-
Price
-
$213.97
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2022
701 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2022.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 602 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
of 50.5M outstanding shares and own 95.56% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.97M shares), BlackRock Inc. (5.33M shares), STATE STREET CORP (2.01M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.61M shares), FMR LLC (1.52M shares), Clearbridge Investments, LLC (1.47M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.1M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.01M shares), MACKENZIE FINANCIAL CORP (987K shares), and GEODE CAPITAL MANAGEMENT, LLC (969K shares).
This table shows the top 602 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.